Joseph Fiorillo, M.D.

A senior investigator in a Phase 3 Immunotherapy Vaccine Trial for Prostate Cancer, Dr. Fiorillo is also excited by the improving immunotherapy options for malignancies such as melanoma and lymphoma, as well as furthering similar therapeutic vaccination strategies for breast and ovarian cancers. Having trained and participated in many clinical trials at the National Cancer Institute, I am hopeful that, within our lifetime, we will be able to cure most cancers, he says, ``and those we cannot